Business Context and Reporting Period
This Form 8-K was filed by Zura Bio Limited (formerly JATT Acquisition Corp) on March 21, 2023, reporting events occurring on March 20, 2023. The company is incorporated in the Cayman Islands and is designated as an emerging growth company. Its Class A Ordinary Shares (ZURA) and Warrants (ZURAW) trade on the Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure vehicle for a press release rather than a financial statement.
Material Changes
The primary material event disclosed is the issuance of a press release (Exhibit 99.1) on March 21, 2023, pursuant to Regulation FD. The filing confirms the company's former name was JATT Acquisition Corp.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained in Item 7.01 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the text does not contain specific guidance, management commentary, risk factors, or details on contingencies within the body of this 8-K; these details are contained in the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 21, 2023) for the specific details of the Regulation FD disclosure.
- Verify the trading status of Class A Ordinary Shares (ZURA) and Warrants (ZURAW) on Nasdaq.
- Confirm the company's status as an emerging growth company and any associated reporting exemptions.
- Check for subsequent filings that may incorporate the press release by reference.